Author

Hermione Price

Unknown affiliation - Cited by 1,052

Biography

Hermione Price is affiliated toSouthern Health NHS Foundation Trust, University of Southampton, United Kingdom . she is a recipient of many awards and grants for her valuable contributions and discoveries in major area of subject research. Her international experience includes various programs, contributions and participation in different countries for diverse fields of study. Her research interests reflect in her wide range of publications in various national and international journals. 
Title
Cited by
Year
Efficacy and safety of once-weekly semaglutide 1.0 mg vs once-daily liraglutide 1.2 mg as add-on to 1–3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10)
MS Capehorn, AM Catarig, JK Furberg, A Janez, HC Price, S Tadayon, ...Diabetes & metabolism 46 (2), 100-109, 2020202
219
2020
Non‐attendance at diabetes outpatient appointments: a systematic review
S Brewster, J Bartholomew, RIG Holt, H PriceDiabetic Medicine 37 (9), 1427-1442, 2020202
68
2020
Use and effectiveness of a fixed‐ratio combination of insulin degludec/liraglutide (IDegLira) in a real‐world population with type 2 diabetes: results from a European …
H Price, M Blüher, R Prager, TM Phan, BL Thorsted, B Schultes, ...Diabetes, Obesity and Metabolism 20 (4), 954-962, 2018201
65
2018
Mechanisms in endocrinology: Antipsychotic medication and type 2 diabetes and impaired glucose regulation
CA Whicher, HC Price, RIG HoltEuropean Journal of Endocrinology 178 (6), R245-R258, 2018201
50
2018
The role of community pharmacists and their position in the delivery of diabetes care: an update for medical professionals
S Brewster, R Holt, J Portlock, H PricePostgraduate medical journal 96 (1138), 473-479, 2020202
25
2020
The use of liraglutide 3.0 mg daily in the management of overweight and obesity in people with schizophrenia, schizoaffective disorder and first episode psychosis: Results of a …
CA Whicher, HC Price, P Phiri, S Rathod, K Barnard‐Kelly, K Ngianga, ...Diabetes, Obesity and Metabolism (6), 1262-1271, 2021202
23
2021
Completion of annual diabetes care processes and mortality: a cohort study using the National Diabetes Audit for England and Wales
N Holman, P Knighton, J OʼKeefe, SH Wild, S Brewster, H Price, K Patel, ...Diabetes, Obesity and Metabolism 23 (12), 2728-2740, 2021202
14
2021
Liraglutide and the management of overweight and obesity in people with schizophrenia, schizoaffective disorder and first-episode psychosis: protocol for a pilot trial
CA Whicher, HC Price, P Phiri, S Rathod, K Barnard-Kelly, C Reidy, ...Trials 20 (1), 1-10, 2019201
13
2019
Royal College of Psychiatrists Liaison Faculty & Joint British Diabetes Societies (JBDS): Guidelines for the management of diabetes in adults and children with psychiatric …
HC Price, K Ismail, ...Diabetic Medicine 35 (8), 997-04, 2018201
10
2018
Evaluating the long‐term cost‐effectiveness of fixed‐ratio combination insulin degludec/liraglutide (IDegLira) for type 2 diabetes in Spain based on real‐world clinical evidence
PM Raya, FJA Blasco, B Hunt, V Martin, BL Thorsted, A Basse, H PriceDiabetes, Obesity and Metabolism 21 (6), 1349-1356, 2019201
10
2019
Population stratification in type 2 diabetes mellitus: a systematic review
S Hodgson, S Cheema, Z Rana, D Olaniyan, E O’Leary, H Price, ...Diabetic Medicine 39 (1), e146, 2022202
8
2022
Prevalence of mental disorders in people living with type 1 diabetes: A systematic literature review and meta-analysis
M Benton, B Cleal, M Prina, J Baykoca, I Willaing, H Price, K IsmailGeneral Hospital Psychiatry, 2022202
6
2022
Routine islet autoantibody testing in clinically diagnosed adult-onset type 1 diabetes can help identify misclassification and the possibility of successful insulin cessation
RJ Eason, NJ Thomas, AV Hill, BA Knight, A Carr, AT Hattersley, ...Diabetes Care 4 (12), 2844-281, 2022202
5
2022
Liraglutide and the management of overweight and obesity in people with severe mental illness: qualitative sub-study
K Barnard-Kelly, CA Whicher, HC Price, P Phiri, S Rathod, C Asher, ...BMC psychiatry 22 (1), 21, 2022202
4
2022
Efficacy and safety of semaglutide 1.0 mg once weekly vs liraglutide 1.2 mg once daily as add-on to 1-3 oral antidiabetic drugs in subjects with Type 2 diabetes (SUSTAIN 10)
Efficacy and safety of semaglutide 1.0 mg once weekly vs liraglutide 1.2 mg once daily as add-on to 1- oral antidiabetic drugs in subjects with Type 2 diabetes (SUSTAIN 10)M Capehorn, A Janez, H Price, B Verges, AM Catarig, JK Furberg, ...DIABETIC MEDICINE 6, 172-172, 2019201
3
2019
The role of community pharmacists in the delivery of diabetes care
S Brewster, R Holt, J Portlock, H PriceDiabetic Medicine 37 (10), 1653-1654, 000
2
2020
Screening for pancreatic ductal adenocarcinoma in the population with diabetes
P Sharp, B Brown, H PricePractical Diabetes 38 (1), 37-40a, 010
2
2021
Healthcare professional awareness of eating disorders in people with type 1 diabetes: a staff survey
Healthcare professional awareness of eating disorders in people with type diabetes: a staff surveyS Brewster, H Partridge, C Cross, H PriceBritish Journal of Diabetes 20 (2), 22-29, 2020202
1
2020
647-P: Efficacy and Safety of GLP-1RAs with or without Baseline SGLT2i: Post-hoc Analysis of the SUSTAIN 10 Trial
647-P: Efficacy and Safety of GLP-RAs with or without Baseline SGLT2i: Post-hoc Analysis of the SUSTAIN 0 TrialM Capehorn, AM Catarig, O Frenkel, C Hindsberger, M Marre, H Price, ...Diabetes 70 (Supplement_), 20220
1
2021
The WISDOM self‐management intervention: A cost‐effectiveness analysis to support the transformation of type 2 diabetes care in England
S Singh, H Price, K Fayers, J Leal, V Donoghue, J Hempenstall, P Lewis, ...Diabetic Medicine 39 (0), e4928, 2022202
1
2022

Referred From: https://scholar.google.com/citations?user=OxDGGP4AAAAJ&hl=en

Cited by
Citations 1052
h-index 14
i10-index 22
Open Access Journals